Management of bleeding and invasive procedures in haemophilia A patients with inhibitor treated with emicizumab (Hemlibra®): Proposals from the French network on inherited bleeding disorders (MHEMO), the French Reference Centre on Haemophilia, in collaboration with the French Working Group on Perioperative Haemostasis (GIHP)
Journal article published in 2019 by
Sophie Susen 
,
Yves Gruel,
Anne Godier,
Annie Harroche,
Herve Chambost,
Dominique Lasne ,
Antoine Rauch,
Stephanie Roullet,
Pierre Fontana ,
Jenny Goudemand,
Emmanuel de Maistre,
Valerie Chamouard,
Bénédicte Wibaut,
Pierre Albaladejo,
Claude Négrier
,
Yves Gruel,
Anne Godier,
Annie Harroche,
Herve Chambost,
Dominique Lasne ,
Antoine Rauch,
Stephanie Roullet,
Pierre Fontana ,
Jenny Goudemand,
Emmanuel de Maistre,
Valerie Chamouard,
Bénédicte Wibaut,
Pierre Albaladejo,
Claude Négrier
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 